<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01858532</url>
  </required_header>
  <id_info>
    <org_study_id>M11-352</org_study_id>
    <secondary_id>2012-005848-21</secondary_id>
    <nct_id>NCT01858532</nct_id>
  </id_info>
  <brief_title>Study Of Diabetic Nephropathy With Atrasentan</brief_title>
  <acronym>SONAR</acronym>
  <official_title>A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy. SONAR: Study Of Diabetic Nephropathy With Atrasentan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AbbVie</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective was to evaluate the effect of atrasentan compared with placebo on time to
      doubling of serum creatinine (DBSC) or the onset of end-stage renal disease (ESRD) in
      participants with type 2 diabetes and nephropathy who were treated with the maximum tolerated
      labeled daily dose (MTLDD) of a renin-angiotensin system (RAS) inhibitor. In addition, the
      study assessed the effects of atrasentan compared with placebo on cardiovascular (CV)
      morbidity and mortality, urine albumin excretion, changes in estimated glomerular filtration
      rate (eGFR), as well as the impact on quality of life in participants with type 2 diabetes
      and nephropathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was a Phase 3, prospective, randomized, double-blind, enriched-population, placebo
      controlled, multicenter study in adult participants with type 2 diabetes and nephropathy.
      Participants who met the inclusion criteria for initial study entry and none of the exclusion
      criteria were eligible to proceed to the Run-In Period to optimize RAS inhibitor and diuretic
      doses. Following the Run-In Period, eligible participants entered the 6-week Enrichment
      Period in which all received atrasentan to determine their urinary albumin to creatinine
      ratio (UACR) response and to assess tolerability of atrasentan. Responders and nonresponders
      were then randomly assigned to receive atrasentan or placebo in the Double-Blind Treatment
      Period. The study was performed in 5 to 6 periods in the following sequence: Pre-Screening
      Period (optional); Screening Period (Visits S1 and S2); Run-In Period (up to 12 weeks; Visits
      R1 to R6); Enrichment Period (6 weeks; Visits E1 to E5); Double-Blind Treatment Period
      (randomization to final treatment visit); and Follow-Up Period (Final Treatment to F1 visit
      [45 days post treatment] and other post-treatment visits). The study was prematurely
      discontinued because of a lower than expected event rate for the renal composite endpoint,
      which was adjudicated by a blinded independent events adjudication committee (EAC).
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Strategic considerations
  </why_stopped>
  <start_date type="Actual">May 17, 2013</start_date>
  <completion_date type="Actual">March 29, 2018</completion_date>
  <primary_completion_date type="Actual">March 29, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to the First Occurrence of a Component of the Composite Renal Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</measure>
    <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
    <description>Time to the first occurrence of a component of the composite renal endpoint was defined as doubling of serum creatinine (confirmed by a 30-day serum creatinine measurement) or the onset of end stage renal disease (estimated glomerular filtration rate [eGFR] less than 15 ml/min/1.73 m^2 confirmed by a 90-day eGFR measurement, receiving chronic dialysis, renal transplantation, or renal death). Only events adjudicated by the Events Adjudication Committee (EAC) were considered in defining this endpoint. Data are presented as number of participants with a primary renal composite event (first event per participant).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to a 50% Estimated Glomerular Filtration Rate Reduction in the Intent-to-Treat (ITT) Responder Set (as Randomized)</measure>
    <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
    <description>The event of interest for this outcome was a 50% reduction in a participant's estimated glomerular filtration rate (eGFR) value as compared to baseline, confirmed by a repeated value at least 20 days apart. The event time was defined as the first time that a 50% reduction in eGFR was observed. Data are presented as number of participants with a 50% reduction in eGFR (first event per participant).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Cardio-renal Composite Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</measure>
    <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
    <description>The composite event of interest for this outcome consisted of doubling of serum creatinine, end-stage renal disease (ESRD), cardiovascular (CV) death (including CV death and presumed CV death), nonfatal myocardial infarction (MI; heart attack) and nonfatal stroke. Presumed sudden cardiac death was included as a subcategory of presumed CV death. Only events adjudicated by the Events Adjudication Committee (EAC) were considered in defining this endpoint. Data are presented as number of participants with a cardio-renal composite event (first event per participant).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Occurrence of a Component of Composite Renal Endpoint for All Randomized Participants (Pooled)</measure>
    <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
    <description>Time to the first occurrence of a component of the composite renal endpoint was defined as doubling of serum creatinine (confirmed by a 30-day serum creatinine measurement) or the onset of end stage renal disease (estimated glomerular filtration rate [eGFR] less than 15 ml/min/1.73 m^2 confirmed by a 90-day eGFR measurement, receiving chronic dialysis, renal transplantation, or renal death). Data for all randomized participants were pooled by treatment and analyzed. Data are presented as number of participants with a renal composite event (first event per participant).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the Cardiovascular Composite Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</measure>
    <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
    <description>The composite event of interest for this outcome was cardiovascular (CV) death (CV death, presumed CV death), nonfatal myocardial infarction (MI; heart attack), and nonfatal stroke. Presumed sudden cardiac death was included as a sub-category of presumed CV death. Only events adjudicated by the Events Adjudication Committee (EAC) were used. Data are presented as number of participants with a cardiovascular composite event (first event per participant).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5107</enrollment>
  <condition>Diabetic Nephropathy</condition>
  <arm_group>
    <arm_group_label>Atrasentan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.75 mg atrasentan once daily by mouth for up to 52 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo once daily by mouth for up to 52 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atrasentan</intervention_name>
    <description>Film-coated tablet</description>
    <arm_group_label>Atrasentan</arm_group_label>
    <other_name>ABT-627</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Film-coated tablet</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant, or legal representative, had voluntarily signed and dated an Informed
             Consent Form, approved by an Institutional Review Board (IRB)/Independent Ethics
             Committee (IEC), after the nature of the study had been explained and the participant
             had the opportunity to ask questions. The informed consent must have been signed
             before any study-specific procedures were performed.

          -  Participant had type 2 diabetes (including participants with latent autoimmune
             diabetes or insulin-treated participants without a history of diabetic ketoacidosis
             who also had a negative anti-glutamic acid decarboxylase test AND an elevated
             post-prandial serum C-peptide level) and had been treated with at least one
             anti-hyperglycemic medication and an angiotensin-converting enzyme inhibitor (ACEi) or
             Angiotensin II receptor blocker (ARB; RAS inhibitor) for at least 4 weeks prior to the
             Screening S2 visit.

          -  For entry into the Run-In Period the participant must have satisfied the following
             criteria based on the Screening laboratory values:

               -  Estimated glomerular filtration rate (eGFR) 25 to 75 mL/min/1.73 m^2 [until the
                  eGFR cap on participants (approximately 300) with a baseline of &gt; 60 mL/min/1.73
                  m^2 was reached] and a urine albumin creatinine ratio (UACR) greater than or
                  equal to 300 and less than 5,000 mg/g (greater than or equal to 34 mg/mmol and
                  less than 565 mg/mmol);

               -  Serum albumin greater than or equal to 2.5 g/dL (25 g/L);

               -  Brain natriuretic peptide (BNP) less than or equal to 200 pg/mL (200 ng/L);

               -  Systolic blood pressure (SBP) greater than or equal to 110 and less than or equal
                  to 180 mmHg;

               -  Serum potassium greater than or equal to 3.5 mEq/L (3.5 mmol/L) and less than or
                  equal to 6.0 mEq/L (6.0 mmol/L);

               -  Participants on a maximum tolerated labeled daily dose (MTLDD) of a RAS inhibitor
                  for greater than or equal to 4 weeks and on a diuretic at the time of screening
                  and who satisfied the above criteria may have proceeded to the last visit in the
                  Run-In Period (R6);

               -  Participants already on a MTLDD of a RAS inhibitor for greater than or equal to 4
                  weeks and not on a diuretic (unless medically contraindicated) at the time of
                  Screening were to start with a diuretic and participate in Run-In for at least 2
                  weeks.

          -  For entry into the Enrichment Period the participant must have satisfied the following
             criteria based on the last visit of the Run-In Period:

               -  RAS inhibitor at the MTLDD for the previous 4 weeks with no adjustments of the
                  dose;

               -  Participants that were on a MTLDD RAS inhibitor and not on a diuretic (unless
                  medically contraindicated) at the time of Screening must have been in Run-In for
                  at least 2 weeks.

          -  For entry into the Double-Blind Treatment Period, participants must have satisfied the
             following criteria based on the last visit of the Enrichment Period:

               -  RAS inhibitor at the MTLDD for the previous 6 weeks during the Enrichment Period
                  with no adjustments of the dose;

               -  Diuretic at any dose unless medically contraindicated or clinically intolerable
                  in the investigator's judgement (i.e., hypotension or hypokalemia);

               -  Participants must not have had a weight change greater than or equal to 3 kg from
                  the beginning of Enrichment to the end of the Enrichment Period and absolute
                  serum BNP greater than or equal to 300 pg/mL (300 ng/L) at the last Enrichment
                  visit;

               -  Participants must not have had an increase in serum creatinine greater than 0.5
                  mg/dL and greater than 20% increase from the beginning of Enrichment to the end
                  of the Enrichment Period.

        Exclusion Criteria:

        A participant was not eligible for entry into the Run-in Period if he/she met any of the
        following criteria:

          -  Participant had a history of severe peripheral edema or facial edema requiring
             diuretics unrelated to trauma or a history of myxedema in the prior 4 weeks to the
             initial Screening S1 visit.

          -  Participant had a history of pulmonary hypertension, pulmonary fibrosis or any lung
             diseases requiring oxygen therapy (e.g., chronic obstructive pulmonary disease,
             emphysema).

          -  Participant had a documented diagnosis of heart failure, previous hospitalization for
             heart failure or current or constellation of symptoms (dyspnea on exertion, pedal
             edema, orthopnea, paroxysmal nocturnal dyspnea) felt to be compatible with heart
             failure, that was not explained by other causes, and for which there was a change in
             medication or other management directed at heart failure.

          -  Participant had known non-diabetic kidney disease (other than kidney stones).

          -  Participant had elevated liver enzymes (serum alanine aminotransaminase [ALT] and/or
             serum aspartate aminotransaminase [AST]) &gt; 3 Ã— the upper limit of normal (ULN).

          -  Participant had hemoglobin &lt; 9 g/dL (90 g/L).

          -  Participant had a sensitivity to loop diuretics.

          -  Participant had a history of an allergic reaction or significant sensitivity to
             atrasentan (or its excipients) or similar compounds.

          -  Participant had a history of chronic gastrointestinal disease, which, in the
             Investigator's opinion, may have caused significant GI malabsorption.

          -  Participant had a history of secondary hypertension (i.e., hemodynamically significant
             renal artery stenosis, primary aldosteronism or pheochromocytoma).

          -  Participant had significant comorbidities (e.g., advanced malignancy, advanced liver
             disease) with a life expectancy of less than 1 year.

          -  Participant had clinically significant cerebrovascular disease (CVD) or coronary
             artery disease (CAD) within 3 months prior to the Screening S1 visit, defined as one
             of the following:

               -  Hospitalization for MI or unstable angina; or

               -  New onset angina with positive functional study or coronary angiogram revealing
                  stenosis; or

               -  Coronary revascularization procedure; or

               -  Transient Ischemic Attack or Stroke.

          -  Participant had received any investigational drug including atrasentan within 3 months
             prior to the Screening S1 visit.

          -  Participant received dialysis treatments or was expected to receive dialysis or renal
             transplant within 6 months of screening.

          -  Participant was currently receiving rosiglitazone, moxonidine, aldosterone blockers,
             aliskiren or a combination of ACEi and ARB.

          -  Participant was a premenopausal woman defined as (for study purposes) any female
             subject with a menses in the past 2 years. For women who were &lt; 50 years old, serum
             FSH must have been greater than 35 IU/L. Women who were surgically sterile or had a
             history of hysterectomy may not have necessarily be postmenopausal, and must also have
             had an FSH &gt; 35 IU/L.

          -  Participant was at high risk for QT/QTc prolongation such as a family history of Long
             QT Syndrome, defined as QTc prolongation exceeding 450 ms in men, or 460 ms in women.

          -  Participant had type 1 diabetes.

          -  Participant was considered to be clinically unstable regarding general, metabolic or
             cardiovascular health as determined by the Investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AbbVie Inc.</last_name>
    <role>Study Director</role>
    <affiliation>AbbVie</affiliation>
  </overall_official>
  <removed_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>China</country>
    <country>Czech Republic</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hong Kong</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Peru</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Puerto Rico</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </removed_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>May 17, 2013</study_first_submitted>
  <study_first_submitted_qc>May 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2013</study_first_posted>
  <results_first_submitted>March 29, 2019</results_first_submitted>
  <results_first_submitted_qc>March 29, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 24, 2019</results_first_posted>
  <last_update_submitted>March 29, 2019</last_update_submitted>
  <last_update_submitted_qc>March 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Nephropathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Diabetic Nephropathies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrasentan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 19, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/32/NCT01858532/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 20, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/32/NCT01858532/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>5107 participants dosed in Enrichment Period (EP); 1441 prematurely discontinued Tx or did not proceed to Double-Blind Treatment Period per criteria. 3666 participants completed EP and proceeded to Double-Blind Treatment Period, along with 2 additional participants who discontinued study drug in EP but were randomized in error.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Intent-to-Treat (ITT) Responder Atrasentan</title>
          <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive atrasentan in the Double-Blind Treatment Period</description>
        </group>
        <group group_id="P2">
          <title>Intent-to-Treat (ITT) Responder Placebo</title>
          <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive placebo in the Double-Blind Treatment Period</description>
        </group>
        <group group_id="P3">
          <title>Intent-to-Treat (ITT) Non-responder Atrasentan</title>
          <description>Participants who achieved &lt; 30% reduction in their urinary albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive atrasentan in the Double-Blind Treatment Period</description>
        </group>
        <group group_id="P4">
          <title>Intent-to-Treat (ITT) Non-responder Placebo</title>
          <description>Participants who achieved &lt; 30% reduction in their urinary albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive placebo in the Double-Blind Treatment Period</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1325"/>
                <participants group_id="P2" count="1323"/>
                <participants group_id="P3" count="509"/>
                <participants group_id="P4" count="511"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1144"/>
                <participants group_id="P2" count="1131"/>
                <participants group_id="P3" count="411"/>
                <participants group_id="P4" count="418"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="181"/>
                <participants group_id="P2" count="192"/>
                <participants group_id="P3" count="98"/>
                <participants group_id="P4" count="93"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="28"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrew consent</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="93"/>
                <participants group_id="P3" count="46"/>
                <participants group_id="P4" count="27"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Deterioration of medical status</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Investigator request</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other, not specified</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="13"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP]) and ITT Non-responders (Participants who achieved &lt; 30% reduction in their UACR in the EP)</population>
      <group_list>
        <group group_id="B1">
          <title>Intent-to-Treat (ITT) Responder Atrasentan</title>
          <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive atrasentan in the Double-Blind Treatment Period</description>
        </group>
        <group group_id="B2">
          <title>Intent-to-Treat (ITT) Responder Placebo</title>
          <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive placebo in the Double-Blind Treatment Period</description>
        </group>
        <group group_id="B3">
          <title>Intent-to-Treat (ITT) Non-responder Atrasentan</title>
          <description>Participants who achieved &lt; 30% reduction in their urinary albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive atrasentan in the Double-Blind Treatment Period</description>
        </group>
        <group group_id="B4">
          <title>Intent-to-Treat (ITT) Non-responder Placebo</title>
          <description>Participants who achieved &lt; 30% reduction in their urinary albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive placebo in the Double-Blind Treatment Period</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1325"/>
            <count group_id="B2" value="1323"/>
            <count group_id="B3" value="509"/>
            <count group_id="B4" value="511"/>
            <count group_id="B5" value="3668"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.9" spread="8.64"/>
                    <measurement group_id="B2" value="64.7" spread="8.66"/>
                    <measurement group_id="B3" value="63.8" spread="9.12"/>
                    <measurement group_id="B4" value="63.6" spread="8.93"/>
                    <measurement group_id="B5" value="64.5" spread="8.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="331"/>
                    <measurement group_id="B2" value="352"/>
                    <measurement group_id="B3" value="127"/>
                    <measurement group_id="B4" value="136"/>
                    <measurement group_id="B5" value="946"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="994"/>
                    <measurement group_id="B2" value="971"/>
                    <measurement group_id="B3" value="382"/>
                    <measurement group_id="B4" value="375"/>
                    <measurement group_id="B5" value="2722"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="76"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="446"/>
                    <measurement group_id="B2" value="455"/>
                    <measurement group_id="B3" value="143"/>
                    <measurement group_id="B4" value="154"/>
                    <measurement group_id="B5" value="1198"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                    <measurement group_id="B2" value="76"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="39"/>
                    <measurement group_id="B5" value="224"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="753"/>
                    <measurement group_id="B2" value="744"/>
                    <measurement group_id="B3" value="313"/>
                    <measurement group_id="B4" value="300"/>
                    <measurement group_id="B5" value="2110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to the First Occurrence of a Component of the Composite Renal Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</title>
        <description>Time to the first occurrence of a component of the composite renal endpoint was defined as doubling of serum creatinine (confirmed by a 30-day serum creatinine measurement) or the onset of end stage renal disease (estimated glomerular filtration rate [eGFR] less than 15 ml/min/1.73 m^2 confirmed by a 90-day eGFR measurement, receiving chronic dialysis, renal transplantation, or renal death). Only events adjudicated by the Events Adjudication Committee (EAC) were considered in defining this endpoint. Data are presented as number of participants with a primary renal composite event (first event per participant).</description>
        <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
        <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP])</population>
        <group_list>
          <group group_id="O1">
            <title>Intent-to-Treat (ITT) Responder Atrasentan</title>
            <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive atrasentan in the Double-Blind Treatment Period</description>
          </group>
          <group group_id="O2">
            <title>Intent-to-Treat (ITT) Responder Placebo</title>
            <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive placebo in the Double-Blind Treatment Period</description>
          </group>
        </group_list>
        <measure>
          <title>Time to the First Occurrence of a Component of the Composite Renal Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</title>
          <description>Time to the first occurrence of a component of the composite renal endpoint was defined as doubling of serum creatinine (confirmed by a 30-day serum creatinine measurement) or the onset of end stage renal disease (estimated glomerular filtration rate [eGFR] less than 15 ml/min/1.73 m^2 confirmed by a 90-day eGFR measurement, receiving chronic dialysis, renal transplantation, or renal death). Only events adjudicated by the Events Adjudication Committee (EAC) were considered in defining this endpoint. Data are presented as number of participants with a primary renal composite event (first event per participant).</description>
          <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP])</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1325"/>
                <count group_id="O2" value="1323"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The endpoint was analyzed using the stratified log-rank test for treatment comparison.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>=0.029</p_value>
            <method>Stratified log-rank test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A Cox Proportional Hazards regression model with pre-specified covariates adjusted was used to estimate the hazard ratio of atrasentan to placebo and its 95% confidence interval.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>=0.005</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.654</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.488</ci_lower_limit>
            <ci_upper_limit>0.878</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to a 50% Estimated Glomerular Filtration Rate Reduction in the Intent-to-Treat (ITT) Responder Set (as Randomized)</title>
        <description>The event of interest for this outcome was a 50% reduction in a participant's estimated glomerular filtration rate (eGFR) value as compared to baseline, confirmed by a repeated value at least 20 days apart. The event time was defined as the first time that a 50% reduction in eGFR was observed. Data are presented as number of participants with a 50% reduction in eGFR (first event per participant).</description>
        <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
        <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP])</population>
        <group_list>
          <group group_id="O1">
            <title>Intent-to-Treat (ITT) Responder Atrasentan</title>
            <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive atrasentan in the Double-Blind Treatment Period</description>
          </group>
          <group group_id="O2">
            <title>Intent-to-Treat (ITT) Responder Placebo</title>
            <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive placebo in the Double-Blind Treatment Period</description>
          </group>
        </group_list>
        <measure>
          <title>Time to a 50% Estimated Glomerular Filtration Rate Reduction in the Intent-to-Treat (ITT) Responder Set (as Randomized)</title>
          <description>The event of interest for this outcome was a 50% reduction in a participant's estimated glomerular filtration rate (eGFR) value as compared to baseline, confirmed by a repeated value at least 20 days apart. The event time was defined as the first time that a 50% reduction in eGFR was observed. Data are presented as number of participants with a 50% reduction in eGFR (first event per participant).</description>
          <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP])</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1325"/>
                <count group_id="O2" value="1323"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78"/>
                    <measurement group_id="O2" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The endpoint was analyzed using the stratified log-rank test for treatment comparison.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>=0.289</p_value>
            <method>Stratified log-rank test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A Cox Proportional Hazards regression model with pre-specified covariates adjusted was used to estimate the hazard ratio of atrasentan to placebo and its 95% confidence interval.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.112</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.779</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.573</ci_lower_limit>
            <ci_upper_limit>1.060</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Cardio-renal Composite Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</title>
        <description>The composite event of interest for this outcome consisted of doubling of serum creatinine, end-stage renal disease (ESRD), cardiovascular (CV) death (including CV death and presumed CV death), nonfatal myocardial infarction (MI; heart attack) and nonfatal stroke. Presumed sudden cardiac death was included as a subcategory of presumed CV death. Only events adjudicated by the Events Adjudication Committee (EAC) were considered in defining this endpoint. Data are presented as number of participants with a cardio-renal composite event (first event per participant).</description>
        <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
        <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP])</population>
        <group_list>
          <group group_id="O1">
            <title>Intent-to-Treat (ITT) Responder Atrasentan</title>
            <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive atrasentan in the Double-Blind Treatment Period</description>
          </group>
          <group group_id="O2">
            <title>Intent-to-Treat (ITT) Responder Placebo</title>
            <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive placebo in the Double-Blind Treatment Period</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Cardio-renal Composite Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</title>
          <description>The composite event of interest for this outcome consisted of doubling of serum creatinine, end-stage renal disease (ESRD), cardiovascular (CV) death (including CV death and presumed CV death), nonfatal myocardial infarction (MI; heart attack) and nonfatal stroke. Presumed sudden cardiac death was included as a subcategory of presumed CV death. Only events adjudicated by the Events Adjudication Committee (EAC) were considered in defining this endpoint. Data are presented as number of participants with a cardio-renal composite event (first event per participant).</description>
          <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP])</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1325"/>
                <count group_id="O2" value="1323"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="147"/>
                    <measurement group_id="O2" value="172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The endpoint was analyzed using the stratified log-rank test for treatment comparison.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.089</p_value>
            <method>Stratified log-rank test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A Cox Proportional Hazards regression model with pre-specified covariates adjusted was used to estimate the hazard ratio of atrasentan to placebo and its 95% confidence interval.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.049</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.801</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.642</ci_lower_limit>
            <ci_upper_limit>0.999</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Occurrence of a Component of Composite Renal Endpoint for All Randomized Participants (Pooled)</title>
        <description>Time to the first occurrence of a component of the composite renal endpoint was defined as doubling of serum creatinine (confirmed by a 30-day serum creatinine measurement) or the onset of end stage renal disease (estimated glomerular filtration rate [eGFR] less than 15 ml/min/1.73 m^2 confirmed by a 90-day eGFR measurement, receiving chronic dialysis, renal transplantation, or renal death). Data for all randomized participants were pooled by treatment and analyzed. Data are presented as number of participants with a renal composite event (first event per participant).</description>
        <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
        <population>Intent-to-treat population: participants who were randomized to receive either atrasentan or placebo during the Double-Blind Treatment Period</population>
        <group_list>
          <group group_id="O1">
            <title>Intent-to-Treat (ITT) Atrasentan</title>
            <description>All randomized participants who entered the Double-Blind Treatment Period and were randomized to receive atrasentan</description>
          </group>
          <group group_id="O2">
            <title>Intent-to-Treat Placebo</title>
            <description>All randomized participants who entered the Double-Blind Treatment Period and were randomized to receive placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Occurrence of a Component of Composite Renal Endpoint for All Randomized Participants (Pooled)</title>
          <description>Time to the first occurrence of a component of the composite renal endpoint was defined as doubling of serum creatinine (confirmed by a 30-day serum creatinine measurement) or the onset of end stage renal disease (estimated glomerular filtration rate [eGFR] less than 15 ml/min/1.73 m^2 confirmed by a 90-day eGFR measurement, receiving chronic dialysis, renal transplantation, or renal death). Data for all randomized participants were pooled by treatment and analyzed. Data are presented as number of participants with a renal composite event (first event per participant).</description>
          <population>Intent-to-treat population: participants who were randomized to receive either atrasentan or placebo during the Double-Blind Treatment Period</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1834"/>
                <count group_id="O2" value="1834"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152"/>
                    <measurement group_id="O2" value="192"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A Cox Proportional Hazards regression model with pre-specified covariates adjusted was used to estimate the hazard ratio of atrasentan to placebo and its 95% confidence interval.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.58</ci_lower_limit>
            <ci_upper_limit>0.89</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to the Cardiovascular Composite Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</title>
        <description>The composite event of interest for this outcome was cardiovascular (CV) death (CV death, presumed CV death), nonfatal myocardial infarction (MI; heart attack), and nonfatal stroke. Presumed sudden cardiac death was included as a sub-category of presumed CV death. Only events adjudicated by the Events Adjudication Committee (EAC) were used. Data are presented as number of participants with a cardiovascular composite event (first event per participant).</description>
        <time_frame>From randomization to individual end of observation, up to 53 months</time_frame>
        <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP])</population>
        <group_list>
          <group group_id="O1">
            <title>Intent-to-Treat (ITT) Responder Atrasentan</title>
            <description>Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive atrasentan in the Double-Blind Treatment Period</description>
          </group>
          <group group_id="O2">
            <title>Intent-to-Treat (ITT) Responder Placebo</title>
            <description>Intent-to-Treat (ITT) Responder Placebo: Participants who achieved at least 30% reduction in their albumin to creatinine ratio (UACR) in the Enrichment Period and were randomized to receive placebo in the Double-Blind Treatment Period</description>
          </group>
        </group_list>
        <measure>
          <title>Time to the Cardiovascular Composite Endpoint in the Intent-to-Treat (ITT) Responder Set (as Randomized)</title>
          <description>The composite event of interest for this outcome was cardiovascular (CV) death (CV death, presumed CV death), nonfatal myocardial infarction (MI; heart attack), and nonfatal stroke. Presumed sudden cardiac death was included as a sub-category of presumed CV death. Only events adjudicated by the Events Adjudication Committee (EAC) were used. Data are presented as number of participants with a cardiovascular composite event (first event per participant).</description>
          <population>Intent-to-Treat (ITT) Responders (participants who achieved at least 30% reduction in their albumin to creatinine ratio [UACR] in the Enrichment Period [EP])</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1325"/>
                <count group_id="O2" value="1323"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The endpoint was analyzed using the stratified log-rank test for treatment comparison.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.446</p_value>
            <method>Stratified log-rank test</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A Cox Proportional Hazards regression model with pre-specified covariates adjusted was used to estimate the hazard ratio of atrasentan to placebo and its 95% confidence interval.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.447</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.884</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.643</ci_lower_limit>
            <ci_upper_limit>1.215</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Treatment-emergent adverse events (TEAEs) and serious adverse events (TESAEs) were reported from the time of study drug administration until 45 days after the last dose of study drug (up to 24 weeks for the All Atrasentan Set in the Enrichment Period; up to 54 months for the ITT sets in the Double-Blind Period)</time_frame>
      <desc>TEAEs and TESAEs are defined as any adverse event (AE) with an onset date that is after the first dose of study drug until 45 days after the last dose of study drug and were collected whether elicited or spontaneously reported by the participant.</desc>
      <group_list>
        <group group_id="E1">
          <title>Enrichment Atrasentan</title>
          <description>Participants who received at least one dose of atrasentan, including both Enrichment and Double-Blind Treatment Periods</description>
        </group>
        <group group_id="E2">
          <title>Double-Blind Atrasentan</title>
          <description>All participants who received at least one dose of atrasentan during the Double-Blind Treatment Period</description>
        </group>
        <group group_id="E3">
          <title>Double-Blind Placebo</title>
          <description>All participants who received at least one dose of placebo during the Double-Blind Treatment Period</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="5107"/>
                <counts group_id="E2" subjects_affected="84" subjects_at_risk="1829"/>
                <counts group_id="E3" subjects_affected="79" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="292" subjects_at_risk="5107"/>
                <counts group_id="E2" subjects_affected="685" subjects_at_risk="1829"/>
                <counts group_id="E3" subjects_affected="626" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5107"/>
                <counts group_id="E2" events="28" subjects_affected="27" subjects_at_risk="1829"/>
                <counts group_id="E3" events="15" subjects_affected="11" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANAEMIA OF CHRONIC DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>AUTOIMMUNE HAEMOLYTIC ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COAGULOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DISSEMINATED INTRAVASCULAR COAGULATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGIC ANAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>IRON DEFICIENCY ANAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LEUKOCYTOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MICROCYTIC ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEPHROGENIC ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEUTROPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PANCYTOPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE CORONARY SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ACUTE LEFT VENTRICULAR FAILURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ACUTE MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5107"/>
                <counts group_id="E2" events="40" subjects_affected="34" subjects_at_risk="1829"/>
                <counts group_id="E3" events="29" subjects_affected="28" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ADAMS-STOKES SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANGINA PECTORIS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="5107"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="1829"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANGINA UNSTABLE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>AORTIC VALVE STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARRHYTHMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARRHYTHMIA SUPRAVENTRICULAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTERIOSCLEROSIS CORONARY ARTERY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="1829"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ATRIAL FLUTTER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ATRIAL TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK COMPLETE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK FIRST DEGREE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK SECOND DEGREE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRADYARRHYTHMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRADYCARDIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK BILATERAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK LEFT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK RIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIAC ARREST</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5107"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="1829"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE ACUTE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CHRONIC</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CONGESTIVE</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="5107"/>
                <counts group_id="E2" events="41" subjects_affected="37" subjects_at_risk="1829"/>
                <counts group_id="E3" events="23" subjects_affected="22" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIO-RESPIRATORY ARREST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIOGENIC SHOCK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIOPULMONARY FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIORENAL SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARDIOVASCULAR DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHRONIC LEFT VENTRICULAR FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISEASE</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5107"/>
                <counts group_id="E2" events="31" subjects_affected="29" subjects_at_risk="1829"/>
                <counts group_id="E3" events="20" subjects_affected="19" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CYANOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIASTOLIC DYSFUNCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE HEART DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ISCHAEMIC CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LEFT VENTRICULAR FAILURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MITRAL VALVE INCOMPETENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5107"/>
                <counts group_id="E2" events="15" subjects_affected="13" subjects_at_risk="1829"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL ISCHAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PALPITATIONS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERICARDIAL EFFUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SINOATRIAL BLOCK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SINUS ARREST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SINUS NODE DYSFUNCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VENTRICULAR EXTRASYSTOLES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VENTRICULAR FIBRILLATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>MENIERE'S DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VERTIGO</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VERTIGO POSITIONAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>GOITRE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERPARATHYROIDISM PRIMARY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>AGE-RELATED MACULAR DEGENERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANGLE CLOSURE GLAUCOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLINDNESS TRANSIENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CATARACT</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="1829"/>
                <counts group_id="E3" events="12" subjects_affected="10" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CATARACT DIABETIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CATARACT NUCLEAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CORNEAL EPITHELIUM DEFECT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CORNEAL OPACITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DACRYOSTENOSIS ACQUIRED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC RETINOPATHY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIPLOPIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>EYE HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>EYELID PTOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GLAUCOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LAGOPHTHALMOS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MACULAR FIBROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MACULAR OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OPTIC ISCHAEMIC NEUROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIORBITAL OEDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RETINAL DETACHMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RETINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RETINOPATHY PROLIFERATIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RHEGMATOGENOUS RETINAL DETACHMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TRACTIONAL RETINAL DETACHMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VISUAL IMPAIRMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VITREOUS ADHESIONS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VITREOUS HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5107"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="5" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL DISTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ABDOMINAL HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANAL INCONTINENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANORECTAL ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ASCITES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHRONIC GASTRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COLITIS ULCERATIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DENTAL CARIES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC GASTROPARESIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC GASTROPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIVERTICULUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIVERTICULUM INTESTINAL HAEMORRHAGIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DUODENAL ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DUODENAL ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DUODENITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DYSPHAGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ENTEROVESICAL FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>EROSIVE DUODENITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRIC DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRIC FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRIC MUCOSAL HYPERTROPHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRIC POLYPS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRIC ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRIC ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRITIS HAEMORRHAGIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL MUCOSAL DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTROOESOPHAGEAL REFLUX DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMORRHOIDS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HIATUS HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ILEUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>IMPAIRED GASTRIC EMPTYING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTESTINAL PERFORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>IRRITABLE BOWEL SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINE PERFORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINE POLYP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LOWER GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LYMPHOCYTIC OESOPHAGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MELAENA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OBSTRUCTIVE PANCREATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL SPASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OESOPHAGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PANCREATIC DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PANCREATITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PANCREATITIS ACUTE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PEPTIC ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PEPTIC ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROCTITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RECTAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RECTAL POLYP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RECTAL ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ULCERATIVE GASTRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>UMBILICAL HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>UPPER GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ASTHENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRAIN DEATH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHEST DISCOMFORT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHEST PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHILLS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DEATH</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DISEASE COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FACE OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FEELING ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GENERAL PHYSICAL HEALTH DETERIORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GENERALISED OEDEMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOTHERMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>IMPAIRED HEALING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INFLUENZA LIKE ILLNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MULTIPLE ORGAN DYSFUNCTION SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NECROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NON-CARDIAC CHEST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIPHERAL SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SUDDEN CARDIAC DEATH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SUDDEN DEATH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SYSTEMIC INFLAMMATORY RESPONSE SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VASCULAR STENT STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>BILE DUCT STONE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BILIARY COLIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHOLANGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS CHRONIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DRUG-INDUCED LIVER INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GALLBLADDER PERFORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATIC CIRRHOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATIC LESION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATIC STEATOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATITIS ACUTE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>ALLERGY TO ARTHROPOD BITE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANAPHYLACTIC SHOCK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DRUG HYPERSENSITIVITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERSENSITIVITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ABSCESS LIMB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ABSCESS SOFT TISSUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ACUTE SINUSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANAL ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTERIOSCLEROTIC GANGRENE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTHRITIS BACTERIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTHRITIS INFECTIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BACTERAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BACTERIAL DIARRHOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BACTERIAL SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BILIARY SEPSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRAIN ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRONCHITIS BACTERIAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CAMPYLOBACTER GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CAMPYLOBACTER INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5107"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="1829"/>
                <counts group_id="E3" events="24" subjects_affected="22" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CELLULITIS GANGRENOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS INFECTIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHRONIC TONSILLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIAL SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIUM DIFFICILE COLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIUM DIFFICILE INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CYSTITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CYSTITIS KLEBSIELLA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DENGUE FEVER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DEVICE RELATED INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC FOOT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC GANGRENE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>EMPHYSEMATOUS PYELONEPHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ENDOCARDITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ENDOPHTHALMITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ENTERITIS INFECTIOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ENTEROBACTER INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ENTEROCOCCAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ERYSIPELAS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA BACTERAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GANGRENE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GAS GANGRENE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1829"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GRAFT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HELICOBACTER INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATITIS B</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATITIS C</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HERPES ZOSTER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INFECTED SKIN ULCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INFECTIVE EXACERBATION OF BRONCHIECTASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISCITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>JOINT ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>KLEBSIELLA INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LEPTOSPIROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LIVER ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LOCALISED INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LOWER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUNG INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MASTOIDITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MEDICAL DEVICE SITE INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MORGANELLA INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NECROTISING FASCIITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEUTROPENIC SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NOSOCOMIAL INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ORCHITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS CHRONIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OTITIS EXTERNA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OTITIS MEDIA ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OTITIS MEDIA CHRONIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PANCREATITIS BACTERIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PAROTID ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIODONTITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIRECTAL ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERITONITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERITONSILLAR ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PHARYNGEAL ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PILONIDAL CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5107"/>
                <counts group_id="E2" events="63" subjects_affected="54" subjects_at_risk="1829"/>
                <counts group_id="E3" events="43" subjects_affected="41" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA BACTERIAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA LEGIONELLA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA PARAINFLUENZAE VIRAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA PSEUDOMONAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA STAPHYLOCOCCAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA STREPTOCOCCAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA VIRAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL CELLULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE WOUND INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROSTATIC ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROSTATITIS ESCHERICHIA COLI</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PSEUDOMONAS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PULMONARY TUBERCULOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS CHRONIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RHINITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5107"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="1829"/>
                <counts group_id="E3" events="18" subjects_affected="18" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SEPSIS SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SEPTIC EMBOLUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SEPTIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SEPTIC NECROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SEPTIC SHOCK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SIALOADENITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL BACTERAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>STREPTOCOCCAL BACTERAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SYSTEMIC CANDIDA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TOOTH ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TOXIC SHOCK SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TUBERCULOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5107"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="1829"/>
                <counts group_id="E3" events="15" subjects_affected="12" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION BACTERIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION ENTEROCOCCAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>UROSEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VULVAL ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION STAPHYLOCOCCAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WOUND SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ABDOMINAL WOUND DEHISCENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANKLE FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLADDER INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRAIN CONTUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BURNS SECOND DEGREE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CERVICAL VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CLAVICLE FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CONCUSSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CONTUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CRANIOCEREBRAL INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CYSTITIS RADIATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DISLOCATION OF VERTEBRA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FACIAL BONES FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5107"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="1829"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FEMORAL NECK FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FEMUR FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FIBULA FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FOOT FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FOREIGN BODY IN GASTROINTESTINAL TRACT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GRAFT THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAND FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEAD INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HIP FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HUMERUS FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ILIUM FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INCISIONAL HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>JAW FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>JOINT DISLOCATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LACERATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LIGAMENT SPRAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LIMB INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LIMB TRAUMATIC AMPUTATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LISFRANC FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LOWER LIMB FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUMBAR VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MENISCUS INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MULTIPLE FRACTURES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MUSCLE RUPTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OVERDOSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PANCREATIC LEAK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PATELLA FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PELVIC FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POST CONCUSSION SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL DISCHARGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE WOUND COMPLICATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROCEDURAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PUBIS FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RADIUS FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RIB FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ROAD TRAFFIC ACCIDENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SKIN ABRASION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPINAL COMPRESSION FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPINAL CORD INJURY CERVICAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPINAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SUBARACHNOID HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SUBDURAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SUBDURAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TENDON RUPTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>THERMAL BURN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>THORACIC VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TIBIA FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TOXICITY TO VARIOUS AGENTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TRAUMATIC FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TRAUMATIC HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TRAUMATIC HAEMOTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TRAUMATIC LUNG INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ULNA FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ULNAR NERVE INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION POSTOPERATIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VASCULAR PSEUDOANEURYSM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WOUND</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WOUND COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WOUND DEHISCENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WOUND HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WOUND NECROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BLOOD ALKALINE PHOSPHATASE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLOOD BICARBONATE DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLOOD CREATININE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLOOD GLUCOSE DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLOOD POTASSIUM INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLOOD UREA INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRAIN NATRIURETIC PEPTIDE INCREASED</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ELECTROCARDIOGRAM Q WAVE ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GLOMERULAR FILTRATION RATE DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMOGLOBIN DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HELICOBACTER TEST POSITIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATIC ENZYME INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTRAOCULAR PRESSURE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LIPASE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROSTATIC SPECIFIC ANTIGEN INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROTEIN URINE PRESENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TROPONIN INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINE CYTOLOGY ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>WEIGHT INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>CACHEXIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DECREASED APPETITE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5107"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="1829"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETES MELLITUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETES MELLITUS INADEQUATE CONTROL</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC KETOACIDOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC KETOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC METABOLIC DECOMPENSATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ELECTROLYTE IMBALANCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FLUID OVERLOAD</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FLUID RETENTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GOUT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERCALCAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERGLYCAEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1829"/>
                <counts group_id="E3" events="11" subjects_affected="9" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERKALAEMIA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="5107"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="1829"/>
                <counts group_id="E3" events="19" subjects_affected="16" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERURICAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOALBUMINAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOCALCAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIA</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5107"/>
                <counts group_id="E2" events="24" subjects_affected="22" subjects_at_risk="1829"/>
                <counts group_id="E3" events="14" subjects_affected="12" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOMAGNESAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPONATRAEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOPHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOVOLAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>METABOLIC ACIDOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OBESITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TYPE 2 DIABETES MELLITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTHROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CERVICAL SPINAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COMPARTMENT SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COSTOCHONDRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GOUTY ARTHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMARTHROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC DEGENERATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC DISPLACEMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC PROTRUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>JOINT SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUMBAR SPINAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MENISCAL DEGENERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MOBILITY DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MUSCULAR WEAKNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CHEST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NECK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEUROPATHIC ARTHROPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OSTEITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1829"/>
                <counts group_id="E3" events="19" subjects_affected="16" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OSTEOPOROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>POLYARTHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RHABDOMYOLYSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ROTATOR CUFF SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SACROILIITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SOFT TISSUE NECROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPINAL COLUMN STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPINAL INSTABILITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPINAL LIGAMENT OSSIFICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPINAL OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPONDYLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPONDYLOLISTHESIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SYMPATHETIC POSTERIOR CERVICAL SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SYNOVIAL CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SYNOVITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>THORACIC SPINAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TORTICOLLIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>ACUTE MYELOID LEUKAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA GASTRIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA OF COLON</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA PANCREAS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ADRENAL NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ATYPICAL FIBROXANTHOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BENIGN NEOPLASM OF BLADDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BENIGN NEOPLASM OF THYROID GLAND</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BENIGN RENAL NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BILE DUCT CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLADDER CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLADDER CANCER RECURRENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLADDER CANCER STAGE I, WITH CANCER IN SITU</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLADDER NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLADDER TRANSITIONAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BONE NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRAIN NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRAIN NEOPLASM BENIGN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BREAST CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BREAST CANCER RECURRENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BREAST NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRONCHIAL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARCINOID TUMOUR PULMONARY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHOLANGIOCARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHRONIC LYMPHOCYTIC LEUKAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COLON ADENOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COLON CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COLON NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COLORECTAL CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIFFUSE LARGE B-CELL LYMPHOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ENDOMETRIAL CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GALLBLADDER CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRIC ADENOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTRIC CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL TRACT ADENOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GLIOBLASTOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATIC CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEPATOCELLULAR CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HUERTHLE CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INFLAMMATORY PSEUDOTUMOUR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTESTINAL ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTRADUCTAL PROLIFERATIVE BREAST LESION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LANGERHANS CELL SARCOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LARYNGEAL SQUAMOUS CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LIPOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LIPOSARCOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUNG ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUNG ADENOCARCINOMA STAGE IV</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUNG CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LYMPHOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MALIGNANT PALATE NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>METASTATIC CARCINOMA OF THE BLADDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>METASTATIC MALIGNANT MELANOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>METASTATIC NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MUCINOUS ADENOCARCINOMA OF APPENDIX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGEAL CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEUROENDOCRINE CARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEUROENDOCRINE TUMOUR OF THE LUNG</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL SQUAMOUS CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OROPHARYNGEAL NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OSTEOSARCOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OVARIAN ADENOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OVARIAN CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PANCREATIC CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PANCREATIC CARCINOMA METASTATIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PITUITARY TUMOUR BENIGN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PLASMA CELL MYELOMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER RECURRENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROSTATIC ADENOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PSEUDOMYXOMA PERITONEI</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RECTAL ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RENAL CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RENAL CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RENAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RENAL ONCOCYTOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SINONASAL PAPILLOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SMALL CELL LUNG CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA OF LUNG</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>THYROID NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TRANSITIONAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TRANSITIONAL CELL CARCINOMA RECURRENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>UTERINE LEIOMYOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE MOTOR AXONAL NEUROPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ALTERED STATE OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>APHASIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BALANCE DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRAIN STEM INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CAROTID ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CAROTID ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CARPAL TUNNEL SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CEREBELLAR HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CEREBELLAR INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CEREBRAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CEREBRAL INFARCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CEREBRAL ISCHAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CEREBRAL THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR ACCIDENT</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5107"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="1829"/>
                <counts group_id="E3" events="14" subjects_affected="14" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CERVICOBRACHIAL SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DEMENTIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC COMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC HYPERGLYCAEMIC COMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC HYPEROSMOLAR COMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC NEUROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>EMBOLIC CEREBRAL INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>FACIAL PARALYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGIC STROKE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HEMIPARESIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYDROCEPHALUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIC SEIZURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ISCHAEMIC CEREBRAL INFARCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ISCHAEMIC STROKE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="10" subjects_affected="9" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>IVTH NERVE PARALYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LACUNAR INFARCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LOSS OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>LUMBAR RADICULOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>METABOLIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MIGRAINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MONONEUROPATHY MULTIPLEX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MYELOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MYOCLONUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEUROPATHY PERIPHERAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PARAESTHESIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PRESYNCOPE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>QUADRIPLEGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RADICULOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SCIATICA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SEIZURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SENILE DEMENTIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPINAL CORD DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SPONDYLITIC MYELOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>STATUS EPILEPTICUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1829"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>THALAMIC INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>TRANSIENT ISCHAEMIC ATTACK</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VASCULAR DEMENTIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>DEVICE CAPTURING ISSUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DEVICE DISLOCATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>AGITATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BIPOLAR DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CONFUSIONAL STATE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DELIRIUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DELUSIONAL DISORDER, SOMATIC TYPE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DISORIENTATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DRUG ABUSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INSOMNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MAJOR DEPRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MENTAL STATUS CHANGES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SUICIDAL IDEATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE KIDNEY INJURY</sub_title>
                <counts group_id="E1" events="20" subjects_affected="19" subjects_at_risk="5107"/>
                <counts group_id="E2" events="56" subjects_affected="54" subjects_at_risk="1829"/>
                <counts group_id="E3" events="40" subjects_affected="36" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>AZOTAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLADDER STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CALCULUS URINARY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHRONIC KIDNEY DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC NEPHROPATHY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="23" subjects_affected="17" subjects_at_risk="1829"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>END STAGE RENAL DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="1829"/>
                <counts group_id="E3" events="30" subjects_affected="27" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GLOMERULONEPHRITIS MEMBRANOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMATURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE URINARY TRACT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYDRONEPHROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYDROURETER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEPHROLITHIASIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>NEPHROPATHY TOXIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROTEINURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RENAL ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RENAL IMPAIRMENT</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="1829"/>
                <counts group_id="E3" events="14" subjects_affected="13" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RENAL VASCULITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URETERIC OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URETEROLITHIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URETHRAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINARY BLADDER POLYP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINARY TRACT OBSTRUCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>BENIGN PROSTATIC HYPERPLASIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>EPIDIDYMAL CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>GYNAECOMASTIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PROSTATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SCROTAL OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>UTERINE PROLAPSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ACUTE RESPIRATORY DISTRESS SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ACUTE RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="1829"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ASPIRATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BRONCHOSPASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>CHRONIC OBSTRUCTIVE PULMONARY DISEASE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DYSPNOEA EXERTIONAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>EPISTAXIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMOPTYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMOTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYDROTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERCAPNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOVENTILATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOXIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INTERSTITIAL LUNG DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MEDIASTINAL CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>OBSTRUCTIVE AIRWAYS DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMOMEDIASTINUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMONIA ASPIRATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PNEUMOTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PULMONARY CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PULMONARY EMBOLISM</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PULMONARY HYPERTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PULMONARY MASS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5107"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1829"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RESPIRATORY ARREST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DISTRESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5107"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1829"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>RESTRICTIVE PULMONARY DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SLEEP APNOEA SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ACTINIC KERATOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ANGIOEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DECUBITUS ULCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC CHEIROARTHROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC FOOT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="1829"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ECZEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>INGROWING NAIL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PRURITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SKIN DISCOLOURATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SKIN ULCER</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5107"/>
                <counts group_id="E2" events="10" subjects_affected="5" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>OVERWORK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>ANEURYSM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>AORTIC ANEURYSM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>AORTIC ANEURYSM RUPTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>AORTIC STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTERIAL DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTERIAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTERIOSCLEROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ARTERITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>BLOOD PRESSURE INADEQUATELY CONTROLLED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DEEP VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DIABETIC VASCULAR DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>DRY GANGRENE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>EXTREMITY NECROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="1829"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE CRISIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE EMERGENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOTENSION</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="5107"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1829"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOVOLAEMIC SHOCK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>MALIGNANT HYPERTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>ORTHOSTATIC HYPOTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERIAL OCCLUSIVE DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="10" subjects_affected="7" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERY STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERY THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ISCHAEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIPHERAL VASCULAR DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1829"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>PERIPHERAL VENOUS DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SHOCK HAEMORRHAGIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>SUBCLAVIAN ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>THROMBOPHLEBITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5107"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1829"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>VASCULAR OCCLUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5107"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1829"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1781" subjects_at_risk="5107"/>
                <counts group_id="E2" subjects_affected="1043" subjects_at_risk="1829"/>
                <counts group_id="E3" subjects_affected="1038" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="183" subjects_affected="180" subjects_at_risk="5107"/>
                <counts group_id="E2" events="241" subjects_affected="216" subjects_at_risk="1829"/>
                <counts group_id="E3" events="138" subjects_affected="127" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="108" subjects_affected="103" subjects_at_risk="5107"/>
                <counts group_id="E2" events="116" subjects_affected="99" subjects_at_risk="1829"/>
                <counts group_id="E3" events="110" subjects_affected="103" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" events="1273" subjects_affected="1148" subjects_at_risk="5107"/>
                <counts group_id="E2" events="765" subjects_affected="534" subjects_at_risk="1829"/>
                <counts group_id="E3" events="666" subjects_affected="483" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="152" subjects_affected="145" subjects_at_risk="5107"/>
                <counts group_id="E2" events="274" subjects_affected="180" subjects_at_risk="1829"/>
                <counts group_id="E3" events="278" subjects_affected="169" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="114" subjects_affected="110" subjects_at_risk="5107"/>
                <counts group_id="E2" events="131" subjects_affected="106" subjects_at_risk="1829"/>
                <counts group_id="E3" events="140" subjects_affected="114" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="51" subjects_affected="50" subjects_at_risk="5107"/>
                <counts group_id="E2" events="126" subjects_affected="93" subjects_at_risk="1829"/>
                <counts group_id="E3" events="135" subjects_affected="93" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>HYPERKALAEMIA</sub_title>
                <counts group_id="E1" events="77" subjects_affected="77" subjects_at_risk="5107"/>
                <counts group_id="E2" events="159" subjects_affected="132" subjects_at_risk="1829"/>
                <counts group_id="E3" events="165" subjects_affected="143" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPERURICAEMIA</sub_title>
                <counts group_id="E1" events="85" subjects_affected="84" subjects_at_risk="5107"/>
                <counts group_id="E2" events="105" subjects_affected="101" subjects_at_risk="1829"/>
                <counts group_id="E3" events="106" subjects_affected="105" subjects_at_risk="1830"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIA</sub_title>
                <counts group_id="E1" events="189" subjects_affected="126" subjects_at_risk="5107"/>
                <counts group_id="E2" events="193" subjects_affected="114" subjects_at_risk="1829"/>
                <counts group_id="E3" events="212" subjects_affected="120" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" events="62" subjects_affected="61" subjects_at_risk="5107"/>
                <counts group_id="E2" events="93" subjects_affected="88" subjects_at_risk="1829"/>
                <counts group_id="E3" events="133" subjects_affected="125" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="79" subjects_affected="78" subjects_at_risk="5107"/>
                <counts group_id="E2" events="179" subjects_affected="158" subjects_at_risk="1829"/>
                <counts group_id="E3" events="257" subjects_affected="218" subjects_at_risk="1830"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Global Medical Services</name_or_title>
      <organization>AbbVie</organization>
      <phone>800-633-9110</phone>
      <email>abbvieclinicaltrials@abbvie.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

